The table below summarizes the most recent Milestone Pharmaceuticals insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Milestone Pharmaceuticals insider buys are important for investors to follow.

Date	Insider	Price	Amount
12-5-2022 Insider Buy	David Bharucha Chief Medical Officer	$4.74 CAGR »	$47,410.00 10,000 shares
10-19-2022 Insider Buy	Michael John Tomsicek Director	$5.32 CAGR »	$79,800.00 15,000 shares
10-21-2022 Insider Buy	Debra K. Liebert Director	$5.28 CAGR »	$73,940.00 14,000 shares
10-20-2022 Insider Buy	Richard C. Pasternak Director	$5.20 CAGR »	$52,000.00 10,000 shares
10-19-2022 Insider Buy	Robert James Wills Director	$4.93 CAGR »	$73,950.00 15,000 shares
5-31-2022 Insider Buy	Paul F. Truex Director	$5.60 CAGR »	$28,000.00 5,000 shares
3-19-2020 Insider Buy	Investments, LP Rtw >10% Owner	$10.71 CAGR »	$91,832.63 8,575 shares
3-2-2020 Insider Buy	Investments, LP Rtw >10% Owner	$18.95 CAGR »	$1,483,083.85 78,263 shares
12-31-2019 Insider Buy	Investments, LP Rtw >10% Owner	$15.50 CAGR »	$352,978.22 22,771 shares
1-13-2020 Insider Buy	Investments, LP Rtw >10% Owner	$16.25 CAGR »	$4,387,500.00 270,000 shares
11-20-2019 Insider Buy	Investments, LP Rtw >10% Owner	$16.00 CAGR »	$6,400,000.00 400,000 shares
10-3-2019 Insider Buy	Investments, LP Rtw >10% Owner	$17.79 CAGR »	$144,978.84 8,150 shares
10-15-2019 Insider Buy	Investments, LP Rtw >10% Owner	$17.40 CAGR »	$95,454.83 5,487 shares
5-13-2019 Insider Buy	Holdings A/S Novo >10% Owner	$15.00 CAGR »	$4,999,995.00 333,333 shares
5-8-2019 Insider Buy	BDC CAPITAL INC. >10% Owner	$15.00 CAGR »	$3,000,000.00 200,000 shares
5-9-2019 Insider Buy	Investments, LP Rtw >10% Owner	$15.00 CAGR »	$10,000,005.00 666,667 shares
5-13-2019 Insider Buy	DE Solidarite Des Travailleurs DU Quebec Fonds >10% Owner	$15.00 CAGR »	$6,499,995.00 433,333 shares

Also See: Institutional Holders of MIST
Also See: SEC filings

Below we present the annualized performance delivered by Milestone Pharmaceuticals stock since 12-5-2022 (the date of the most recent insider purchase). The performance of the investment from the time Milestone Pharmaceuticals insider buying occurred is the ultimate test of whether insiders were right about MIST being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	12/06/2022
End date:	04/18/2024
Start price/share:	$4.51
End price/share:	$1.63
Dividends collected/share:	$0.00
Total return:	-63.86%
Average Annual Total Return:	-52.57%
Starting investment:	$10,000.00
Ending investment:	$3,614.20
Years:	1.36

Milestone Pharmaceuticals Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Milestone Pharmaceuticals insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding MIST

MIST — Current Quote

Quotes delayed 20 minutes

Free MIST Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

MIST — Performance

Milestone Pharmaceuticals Insider Buying

Milestone Pharmaceuticals Insider Buying | www.HoldingsChannel.com